McGuff Compounding Pharmacy Services, Inc. is recalling one lot of Dimercaptopropanesulfonate Sodium (DMPS) aqueous injection solution, 50mg/mL in 5 mL single-dose vials. This prescription-only medication was found to contain visible particulate matter in vials that had been released for dispensing. If you have this medication, you should contact your doctor or pharmacist immediately, as the presence of foreign particles in an injectable drug can lead to serious health complications.
Injecting a solution containing particulate matter can cause local irritation, swelling, or infection at the injection site. More seriously, these particles can travel through the bloodstream and lodge in vital organs, potentially causing blockages (embolisms), inflammation, or damage to the heart, lungs, or brain.
Healthcare consultation and pharmacy return.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.